Pegcetacoplan therapy in geographic atrophy (GA): Therapeutic effects on retinal pigment epithelium (RPE) and photoreceptor (PR) integrity and function in the phase III clinical trials (EURETINA 2023 GA) - Apellis Medical Hub

Home / Congress Presentations / Geographic Atrophy / EURETINA 2023

Pegcetacoplan therapy in geographic atrophy (GA): Therapeutic effects on retinal pigment epithelium (RPE) and photoreceptor (PR) integrity and function in the phase III clinical trials

Share Via Email

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.